We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The purpose of the tests is to detect prostate cancer in the early stages, before the disease progresses. There are two common initial screening tests. Depending on the result, you may be referred to a urologist for a biopsy. These initial tests are:
- Rectal examination
- Prostate-specific antigen (PSA) blood test
The PSA blood test seeks to identify a protein in the blood that is specifically produced by prostate cells.
An elevated or rising PSA level alone does not always mean that a man has prostate cancer. PSA levels may increase with age and other benign conditions, such as benign prostatic hyperplasia or prostatitis. To diagnose prostate cancer, you will need to undergo a prostate biopsy.
Depending on the results, you may be referred to a urologist in order to undergo a magnetic resonance imaging (MRI) scan and a biopsy. This is the only way to determine the presence of a cancer.
This is another type of biopsy which uses the images obtained from the MRI scans and real-time ultrasound images. Using a computer programme, the images obtained in the ultrasound scan are fused, or merged, with those of the previously-performed prostate MRI. This allows lesions to be located with greater accuracy. Samples will be taken from the lesion and from the rest of the prostate. The prostate samples will be sent to the anatomopathologist (a specialist who analyses and studies the tissues). After analysing the samples under a microscope, they will confirm whether or not the patient has cancer. If they do have cancer, the anatomopathologist will also confirm how aggressive it is.
We suggest that you talk with your doctor to see whether or not you need to undergo a PSA blood analysis.
Together you can decide on the best way to proceed.
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.